AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
New Technology May Advance AIDS Vaccine Development.(Brief Article)
2001 OCT 10 - (NewsRx.com & NewsRx.net) --
ViroLogic, Inc. announced that an enhanced version of its PhenoSense HIV drug resistance assay can measure the potential effectiveness of AIDS vaccines in development faster, more efficiently and more consistently than currently used methods, according to research presented September 6, 2001, at the AIDS Vaccine 2001 Conference held in Philadelphia, Pennsylvania.
This novel application may help accelerate the search for life-saving vaccines to slow the spread of HIV/AIDS worldwide. Known as a virus neutralization assay, ViroLogic's assay rapidly and accurately measures the ability of antibodies to block HIV infection. If the ViroLogic assay shows that the antibodies elicited by the vaccine effectively stop HIV infection, then that vaccine represents a good candidate for further clinical evaluation.
In the study, scientists from ViroLogic measured the neutralizing activity of well-characterized antibodies. The results obtained using the PhenoSense neutralization assay compared favorably with values obtained using conventional assays, but results were generated much more quickly with the PhenoSense assay (three days) versus the conventional assay (several weeks) due to ViroLogic's proprietary technology platform.
"These findings demonstrate the remarkable flexibility and adaptability of the ...
- ViroLogic Announces Availability of Novel, Rapid HIV Drug Resistance Test,...
- Press release article from: Business Wire June 23, 1999 700+ words
...turnaround time provided by PhenoSense HIV makes phenotypic HIV...commercial availability of ViroLogic's first assay," said...Executive Officer of ViroLogic. "The novel technology offered in PhenoSense HIV presents physicians and...
- ViroLogic Announces Study Published in AIDS Demonstrates Long-Term Predictive...
- Press release article from: PR Newswire April 14, 2003 700+ words
...Clinical Research at ViroLogic and one of the...the use of the PhenoSense HIV assay in combination...efavirenz in the PhenoSense HIV assay was independently...drug therapy. PhenoSense HIV is the only commercial...information. About ViroLogic ViroLogic is...
- Clinical Trial of ViroLogic's PhenoSense HIV Demonstrates Benefits of...
- Press release article from: Business Wire January 19, 2001 700+ words
...Cutoffs Established ViroLogic is implementing...will be used in PhenoSense HIV for samples sent to the ViroLogic clinical laboratory...application of PhenoSense HIV test results...Nicholas Hellmann, ViroLogic's Vice President...
- Research Using PhenoSense HIV Drug Resistance Technology, Presented At 8th...
- Press release article from: Business Wire February 8, 2001 700+ words
...here that utilized ViroLogic's PhenoSense HIV technology were the...treatment with the drug. ViroLogic began incorporating...drugs in December. PhenoSense HIV is the only drug...clinical cutoffs. "ViroLogic has been a leader...
- PhenoSense HIV Drug Resistance Testing Superior to Treatment History in...
- Press release article from: Business Wire January 31, 2001 700+ words
...and marketed by ViroLogic, Inc. (NASDAQ...of a patient's virologic response to therapy...that testing with PhenoSense HIV can improve physician...C and cancer. ViroLogic's first product, PhenoSense HIV, is a test that...
- Attention Focused on Phenotypic HIV Drug Resistance Testing and PhenoSense...
- Newspaper article from: AIDS Weekly February 14, 2000 700+ words
...presentations employing ViroLogic's PhenoSense HIV assay were presented...late breakers used ViroLogic's technology to...abstracts presented used PhenoSense HIV, the only commercially...Presentations employing the ViroLogic assay focused on...
- ViroLogic Announces Availability of Novel, Rapid HIV Drug Resistance Test,...
- Press release article from: PR Newswire June 23, 1999 700+ words
...turnaround time provided by PhenoSense HIV makes phenotypic HIV...commercial availability of ViroLogic's first assay," said...Executive Officer of ViroLogic. "The novel technology offered in PhenoSense HIV presents physicians and...
- ViroLogic Announces $12.6 Million In Private Financing
- Press release article from: PR Newswire August 26, 1998 700+ words
...and Hepatitis C." ViroLogic's PhenoSense HIV evaluates the susceptibility...laboratory application of ViroLogic's PhenoSense HIV were presented at the...individual as shown by ViroLogic's PhenoSense HIV. Experts believe the...